Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words 'HOSKINS WJ' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 62 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Chi, DS; Jones, WB; Barakat, RR; O'Keefe, KN; Hoskins, WJ; Lewis, JL
      The benefit of a special elective gynecologic oncology program for obstetrics and gynecology residents

      EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
    2. Chi, DS; Liao, JB; Leon, LF; Venkatraman, ES; Hensley, ML; Bhaskaran, D; Hoskins, WJ
      Identification of prognostic factors in advanced epithelial ovarian carcinoma

      GYNECOLOGIC ONCOLOGY
    3. Sonoda, Y; Zerbe, M; Smith, A; Lin, O; Barakat, RR; Hoskins, WJ
      High incidence of positive peritoneal cytology in low-risk endometrial cancer treated by laparoscopically assisted vaginal hysterectomy

      GYNECOLOGIC ONCOLOGY
    4. Hornreich, G; Schloss, C; Hoskins, WJ; Muggia, FM
      Doxil-induced radiation recall: A cause for false-positive PET scan findings

      GYNECOLOGIC ONCOLOGY
    5. Park, RC; Hoskins, WJ; Weiner, JM
      When definitive answers are needed

      GYNECOLOGIC ONCOLOGY
    6. Husain, A; Chi, DS; Prasad, M; Abu-Rustum, N; Barakat, RR; Brown, CL; Poynor, EA; Hoskins, WJ; Curtin, JP
      The role of laparoscopy in second-look evaluations for ovarian cancer

      GYNECOLOGIC ONCOLOGY
    7. Abu Rustun, NR; Hoskins, WJ
      Radical abdominal hysterectomy (vol 81, pg 815, 2001)

      SURGICAL CLINICS OF NORTH AMERICA
    8. Samimi, G; Fink, D; Varki, NM; Husain, A; Hoskins, WJ; Alberts, DS; Howell, SB
      Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy

      CLINICAL CANCER RESEARCH
    9. Barakat, RR; Gilewski, TA; Almadrones, L; Saigo, PE; Venkatraman, E; Hudis, C; Hoskins, WJ
      Effect of adjuvant tamoxifen on the endometrium in women with breast cancer: A prospective study using office endometrial biopsy

      JOURNAL OF CLINICAL ONCOLOGY
    10. Boyd, J; Sonoda, Y; Federici, MG; Bogomolniy, F; Rhei, E; Maresco, DL; Saigo, PE; Almadrones, LA; Barakat, RR; Brown, CL; Chi, DS; Curtin, JP; Poynor, EA; Hoskins, WJ
      Clinicopathologic features of BRCA-linked and sporadic ovarian cancer

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    11. Chi, DS; Venkatraman, ES; Masson, V; Hoskins, WJ
      The ability of preoperative serum CA-125 to predict optimal primary tumor cytoreduction in stage III epithelial ovarian carcinoma

      GYNECOLOGIC ONCOLOGY
    12. Chi, DS; Hoskins, WJ
      Primary surgical management of ovarian cancer

      OVARIAN CANCER: METHODS AND PROTOCOLS
    13. Chi, DS; Gemignani, ML; Curtin, JP; Hoskins, WJ
      Long-term experience in the surgical management of cancer of the uterine cervix

      SEMINARS IN SURGICAL ONCOLOGY
    14. Bridgewater, JA; Nelstrop, AE; Rustin, GJS; Gore, ME; McGuire, WP; Hoskins, WJ
      Comparison of standard and CA-125 response criteria in patients with epithelial ovarian cancer treated with platinum or paclitaxel

      JOURNAL OF CLINICAL ONCOLOGY
    15. Begg, CB; Cramer, LD; Hoskins, WJ; Brennan, MF
      Influence of hospital volume on mortality following major cancer surgery -Reply

      JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
    16. BEGG CB; CRAMER LD; HOSKINS WJ; BRENNAN MF
      IMPACT OF HOSPITAL VOLUME ON OPERATIVE MORTALITY FOR MAJOR CANCER-SURGERY

      JAMA, the journal of the American Medical Association
    17. BOENTE MP; CHI DS; HOSKINS WJ
      THE ROLE OF SURGERY IN THE MANAGEMENT OF OVARIAN-CANCER - PRIMARY ANDINTERVAL CYTOREDUCTIVE SURGERY

      Seminars in oncology
    18. FINSTAD CL; LLOYD KO; FEDERICI MG; DIVGI C; VENKATRAMAN E; BARAKAT RR; FINN RD; LARSON SM; HOSKINS WJ; HUMM JL
      DISTRIBUTION OF RADIOLABELED MONOCLONAL-ANTIBODY MX35 F(AB')2 IN TISSUE SAMPLES BY STORAGE PHOSPHOR SCREEN IMAGE-ANALYSIS - EVALUATION OF ANTIBODY LOCALIZATION TO MICROMETASTATIC DISEASE IN EPITHELIAL OVARIAN-CANCER

      Clinical cancer research
    19. HOSKINS WJ; MCGUIRE WP; BRADY MF; KUCERA PR; PARTRIDGE EE; LOOK KY; CLARKEPEARSON DL; DAVIDSON M
      COMBINATION PACLITAXEL (TAXOL(R))-CISPLATIN VS CYCLOPHOSPHAMIDE-CISPLATIN AS PRIMARY THERAPY IN PATIENTS WITH SUBOPTIMALLY DEBULKED ADVANCED OVARIAN-CANCER

      International journal of gynecological cancer
    20. MCGUIRE WP; HOSKINS WJ; BRADY MF; KUCERA PR; PARTRIDGE EE; LOOK KY; CLARKPEARSON DL; DAVIDSON M
      COMPARISON OF COMBINATION THERAPY WITH PACLITAXEL AND CISPLATIN VERSUS CYCLOPHOSPHAMIDE AND CISPLATIN IN PATIENTS WITH SUBOPTIMAL STAGE-IIIAND STAGE-IV OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

      Seminars in oncology
    21. FENNELLY DW; AGHAJANIAN C; SHAPIRO F; OFLAHERTY C; OCONNOR K; CURTIN JP; CROWN JP; HOSKINS WJ; SPRIGGS DR
      DOSE-ESCALATION OF PACLITAXEL WITH HIGH-DOSE CARBOPLATIN USING PERIPHERAL-BLOOD PROGENITOR-CELL SUPPORT IN PATIENTS WITH ADVANCED OVARIAN-CANCER

      Seminars in oncology
    22. CURTIN JP; MALIK R; VENKATRAMAN ES; BARAKAT RR; HOSKINS WJ
      STAGE-IV OVARIAN-CANCER - IMPACT OF SURGICAL DEBULKING

      Gynecologic oncology
    23. HOSKINS WJ
      IN-VITRO AND IN-VIVO STUDIES ON THE DEVELOPMENT OF THE ALPHA-EMITTINGRADIONUCLIDE BISMUTH-212 FOR INTRAPERITONEAL USE AGAINST MICROSCOPIC OVARIAN-CARCINOMA - DISCUSSION

      American journal of obstetrics and gynecology
    24. MCGUIRE WP; HOSKINS WJ; BRADY MF; KUCERA PR; PARTRIDGE EE; LOOK KY; CLARKEPEARSON DL; DAVIDSON M
      COMPARISON OF COMBINATION THERAPY WITH PACLITAXEL TAXOL(R) AND CISPLATIN VERSUS CYCLOPHOSPHAMIDE AND CISPLATIN IN PATIENTS WITH SUBOPTIMAL STAGE-III AND STAGE-IV OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

      International journal of gynecological cancer
    25. ALBERTS DS; LIU PY; HANNIGAN EV; OTOOLE R; WILLIAMS SD; YOUNG JA; FRANKLIN EW; CLARKEPEARSON DL; MALVIYA VK; DUBESHTER B; HOSKINS WJ; ADELSON MD; ALVAREZ RD; OSULLIVAN J; GARCIA DJ; SPARKS DB; QUADE J; ROTHENBERG ML
      PHASE-III STUDY OF INTRAPERITONEAL CISPLATIN-INTRAVENOUS CYCLOPHOSPHAMIDE VERSUS INTRAVENOUS CISPLATIN-INTRAVENOUS CYCLOPHOSPHAMIDE IN PATIENTS WITH OPTIMAL DISEASE STAGE-III OVARIAN-CANCER - A SWOG-GOG-ECOG INTERGROUP STUDY

      International journal of gynecological cancer
    26. RUSTIN GJS; NELSTROP AE; MCCLEAN P; BRADY MF; MCGUIRE WP; HOSKINS WJ; MITCHELL H; LAMBERT HE
      DEFINING RESPONSE OF OVARIAN-CARCINOMA TO INITIAL CHEMOTHERAPY ACCORDING TO SERUM CA-125

      Journal of clinical oncology
    27. MCGUIRE WP; HOSKINS WJ; BRADY MF; KUCERA PR; PARTRIDGE EE; LOOK KY; CLARKEPEARSON DL; DAVIDSON M
      CYCLOPHOSPHAMIDE AND CISPLATIN VERSUS PACLITAXEL AND CISPLATIN - A PHASE-III RANDOMIZED TRIAL IN PATIENTS WITH SUBOPTIMAL STAGE III IV OVARIAN-CANCER (FROM THE GYNECOLOGIC-ONCOLOGY-GROUP)/

      Seminars in oncology
    28. CURTIN JP; HOSKINS WJ; VENKATRAMAN ES; ALMADRONES L; PODRATZ KC; LONG H; TENERIELLO M; AVERETTE H; SEVIN BU
      ADJUVANT CHEMOTHERAPY VERSUS CHEMOTHERAPY PLUS PELVIC IRRADIATION FORHIGH-RISK CERVICAL-CANCER PATIENTS AFTER RADICAL HYSTERECTOMY AND PELVIC LYMPHADENECTOMY (RH-PLND) - A RANDOMIZED PHASE-III TRIAL

      Gynecologic oncology
    29. GOGAS H; SHAPIRO F; AGHAJANIAN C; FENNELLY D; ALMADRONES L; HOSKINS WJ; SPRIGGS DR
      THE IMPACT OF DIABETES-MELLITUS ON THE TOXICITY OF THERAPY FOR ADVANCED OVARIAN-CANCER

      Gynecologic oncology
    30. ABURUSTUM NR; BARAKAT RR; SIEGEL PL; VENKATRAMAN E; CURTIN JP; HOSKINS WJ
      2ND-LOOK OPERATION FOR EPITHELIAL OVARIAN-CANCER - LAPAROSCOPY OR LAPAROTOMY

      Obstetrics and gynecology
    31. STIER EA; BARAKAT RR; CURTIN JP; BROWN CL; JONES WB; HOSKINS WJ
      LAPAROTOMY TO COMPLETE STAGING OF PRESUMED EARLY OVARIAN-CANCER

      Obstetrics and gynecology
    32. ALBERTS DS; LIU PY; HANNIGAN EV; OTOOLE R; WILLIAMS SD; YOUNG JA; FRANKLIN EW; CLARKEPEARSON DL; MALVIYA VK; DUBESHTER B; ADELSON MD; HOSKINS WJ
      INTRAPERITONEAL CISPLATIN PLUS INTRAVENOUS CYCLOPHOSPHAMIDE VERSUS INTRAVENOUS CISPLATIN PLUS INTRAVENOUS CYCLOPHOSPHAMIDE FOR STAGE-III OVARIAN-CANCER

      The New England journal of medicine
    33. MCGUIRE WP; HOSKINS WJ; BRADY MF
      CHEMOTHERAPY FOR OVARIAN-CANCER - REPLY

      The New England journal of medicine
    34. MCGUIRE WP; HOSKINS WJ; BRADY MF; KUCERA PR; PARTRIDGE EE; LOOK KY; CLARKEPEARSON DL; DAVIDSON M
      CYCLOPHOSPHAMIDE AND CISPLATIN COMPARED WITH PACLITAXEL AND CISPLATININ PATIENTS WITH STAGE-III AND STAGE-IV OVARIAN-CANCER

      The New England journal of medicine
    35. YIN BWT; FINSTAD CL; KITAMURA K; FEDERICI MG; WELSHINGER M; KUDRYASHOV V; HOSKINS WJ; WELT S; LLOYD KO
      SEROLOGICAL AND IMMUNOCHEMICAL ANALYSIS OF LEWIS-Y (LE(Y)) BLOOD-GROUP ANTIGEN EXPRESSION IN EPITHELIAL OVARIAN-CANCER

      International journal of cancer
    36. ALBERTS DS; HEDDENS DK; GARCIA DJ; WILLIAMS SD; HANNIGAN EV; HOSKINS WJ; OTOOLE R; QUADE J; OSULLIVAN J
      CHEMOTHERAPY-INDUCED ANEMIA AND PACKED RED-BLOOD-CELL (PRBC) TRANSFUSIONS IN ADVANCED OVARIAN-CANCER PATIENTS ENROLLED IN A PHASE-III STUDYOF CISPLATIN PLUS CYCLOPHOSPHAMIDE

      Blood
    37. HOSKINS WJ
      HISTOLOGIC-CHANGES IN THE OVARIES OF CANCER-PRONE WOMEN - AN INDICATION OF PREMALIGNANT CHANGE

      Journal of the National Cancer Institute
    38. MCGUIRE WP; HOSKINS WJ; BRADY MF; HOMESLEY HD; CREASMAN WT; BERMAN ML; BALL H; BEREK JS; WOODWARD J
      ASSESSMENT OF DOSE-INTENSIVE THERAPY IN SUBOPTIMALLY DEBULKED OVARIAN-CANCER - A GYNECOLOGIC-ONCOLOGY-GROUP STUDY

      Journal of clinical oncology
    39. HOSKINS WJ
      PROSPECTIVE ON OVARIAN-CANCER - WHY PREVENT

      Journal of cellular biochemistry
    40. THIGPEN T; VANCE RB; MCGUIRE WP; HOSKINS WJ; BRADY M
      ROLE OF PACLITAXEL IN THE MANAGEMENT OF CELOMIC EPITHELIAL CARCINOMA OF THE OVARY - A REVIEW WITH EMPHASIS ON THE GYNECOLOGIC-ONCOLOGY-GROUP EXPERIENCE

      Seminars in oncology
    41. BARAKAT RR; BENJAMIN I; LEWIS JL; SAIGO PE; CURTIN JP; HOSKINS WJ
      PLATINUM-BASED CHEMOTHERAPY FOR ADVANCED-STAGE SEROUS OVARIAN-CARCINOMA OF LOW MALIGNANT POTENTIAL

      Gynecologic oncology
    42. KORNBLITH AB; THALER HT; WONG G; VLAMIS V; LEPORE JM; LOSETH DB; HAKES T; HOSKINS WJ; PORTENOY RK
      QUALITY-OF-LIFE OF WOMEN WITH OVARIAN-CANCER

      Gynecologic oncology
    43. POYNOR EA; BARAKAT RR; HOSKINS WJ
      MANAGEMENT AND FOLLOW-UP OF PATIENTS WITH ADENOCARCINOMA IN-SITU OF THE UTERINE CERVIX

      Gynecologic oncology
    44. VACCARELLO L; RUBIN SC; VLAMIS V; WONG G; JONES WB; LEWIS JL; HOSKINS WJ
      CYTOREDUCTIVE SURGERY IN OVARIAN-CARCINOMA PATIENTS WITH A DOCUMENTEDPREVIOUSLY COMPLETE SURGICAL RESPONSE

      Gynecologic oncology
    45. CURTIN JP; SAIGO P; SLUCHER B; VENKATRAMAN ES; MYCHALCZAK B; HOSKINS WJ
      SOFT-TISSUE SARCOMA OF THE VAGINA AND VULVA - A CLINICOPATHOLOGICAL STUDY

      Obstetrics and gynecology
    46. BALCH CM; BLAND KI; BRENNAN MF; CAMERON JL; CHABNER BA; COPELAND EM; HOSKINS WJ; KARAKOUSIS CP; NIEDERHUBER JE; POLLOCK RE; RICHIE JP; ROTH JA; SHAH JP; SHUCK JM; WINCHESTER DP
      WHAT IS A SURGICAL ONCOLOGIST

      Annals of surgical oncology
    47. HOSKINS WJ
      EPITHELIAL OVARIAN-CARCINOMA - PRINCIPLES OF PRIMARY SURGERY

      Gynecologic oncology
    48. BARAKAT RR; WONG G; CURTIN JP; VLAMIS V; HOSKINS WJ
      TAMOXIFEN USE IN BREAST-CANCER PATIENTS WHO SUBSEQUENTLY DEVELOP CORPUS CANCER IS NOT ASSOCIATED WITH A HIGHER INCIDENCE OF ADVERSE HISTOLOGIC FEATURES

      Gynecologic oncology
    49. BENJAMIN I; BARAKAT RR; CURTIN JP; JONES WB; LEWIS JL; HOSKINS WJ
      BLOOD-TRANSFUSION FOR RADICAL HYSTERECTOMY BEFORE AND AFTER THE DISCOVERY OF TRANSFUSION-RELATED HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION

      Obstetrics and gynecology
    50. CURTIN JP; BARAKAT RR; HOSKINS WJ
      OVARIAN DISEASE IN WOMEN WITH BREAST-CANCER

      Obstetrics and gynecology
    51. PORTENOY RK; KORNBLITH AB; WONG G; VLAMIS V; LEPORE JM; LOSETH DB; HAKES T; FOLEY KM; HOSKINS WJ
      PAIN IN OVARIAN-CANCER PATIENTS - PREVALENCE, CHARACTERISTICS, AND ASSOCIATED SYMPTOMS

      Cancer
    52. RUBIN SC; FINSTAD CL; FEDERICI MG; SCHEINER L; LLOYD KO; HOSKINS WJ
      PREVALENCE AND SIGNIFICANCE OF HER-2 NEU EXPRESSION IN EARLY EPITHELIAL OVARIAN-CANCER/

      Cancer
    53. HOSKINS WJ; MCGUIRE WP; BRADY MF; HOMESLEY HD; CREASMAN WT; BERMAN M; BALL H; BEREK JS
      THE EFFECT OF DIAMETER OF LARGEST RESIDUAL DISEASE ON SURVIVAL AFTER PRIMARY CYTOREDUCTIVE SURGERY IN PATIENTS WITH SUBOPTIMAL RESIDUAL EPITHELIAL OVARIAN-CARCINOMA

      American journal of obstetrics and gynecology
    54. HOSKINS WJ
      GYNECOLOGIC SURGERY AND ENDOSCOPY

      Current opinion in obstetrics & gynecology
    55. DAVIDSON SA; RUBIN SC; MYCHALCZAK B; SAIGO PE; LEWIS JL; CHAPMAN D; HOSKINS WJ
      LIMITED-FIELD RADIOTHERAPY AS SALVAGE TREATMENT OF LOCALIZED PERSISTENT OR RECURRENT EPITHELIAL OVARIAN-CANCER

      Gynecologic oncology
    56. JONES WB; MERCER GO; LEWIS JL; RUBIN SC; HOSKINS WJ
      EARLY INVASIVE-CARCINOMA OF THE CERVIX

      Gynecologic oncology
    57. RUBIN SC; KOSTAKOGLU L; DIVGI C; FEDERICI MG; FINSTAD CL; LLOYD KO; LARSON SM; HOSKINS WJ
      BIODISTRIBUTION AND INTRAOPERATIVE EVALUATION OF RADIOLABELED MONOCLONAL-ANTIBODY MX-35 IN PATIENTS WITH EPITHELIAL OVARIAN-CANCER

      Gynecologic oncology
    58. PROVENCHER DM; FINSTAD CL; SAIGO PE; RUBIN SC; HOSKINS WJ; FEDERICI MG; STOCKERT E; LLOYD KO; LEWIS JL
      COMPARISON OF ANTIGEN EXPRESSION ON FRESH AND CULTURED ASCITES-CELLS AND ON SOLID TUMORS OF PATIENTS WITH EPITHELIAL OVARIAN-CANCER

      Gynecologic oncology
    59. WRONSKI M; ZAKOWSKI M; ARBIT E; HOSKINS WJ; GALICICH JH
      ENDOMETRIAL CANCER METASTASIS TO BRAIN - REPORT OF 2 CASES AND A REVIEW OF THE LITERATURE

      Surgical neurology
    60. RUBIN SC; JONES WB; CURTIN JP; BARAKAT RR; HAKES TB; HOSKINS WJ
      2ND-LOOK LAPAROTOMY IN STAGE-I OVARIAN-CANCER FOLLOWING COMPREHENSIVESURGICAL STAGING

      Obstetrics and gynecology
    61. RUBIN SC; WONG GYC; CURTIN JP; BARAKAT RR; HAKES TB; HOSKINS WJ
      PLATINUM-BASED CHEMOTHERAPY OF HIGH-RISK STAGE-I EPITHELIAL OVARIAN-CANCER FOLLOWING COMPREHENSIVE SURGICAL STAGING

      Obstetrics and gynecology
    62. PLANTE M; WONG GY; NISSELBAUM JS; ALMADRONES L; HOSKINS WJ; RUBIN SC
      RELATIONSHIP BETWEEN SALIVA AND SERUM CA-125 IN WOMEN WITH AND WITHOUT EPITHELIAL OVARIAN-CANCER

      Obstetrics and gynecology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 07/08/20 alle ore 02:24:54